approved EB-2 (NIW)

Postdoctoral Fellow

Pharmaceutical Sciences · Vietnam · 2022-03-16

Processing Time
97 days
Decision Date
2022-03-16
Location
Texas
This case is from a publicly available case study. Case studies tend to feature successful outcomes and may not reflect the full range of petition results.

Proposed Endeavor

The petitioner proposes to continue his research on developing inhalable drug delivery systems, specifically inhalable dry powders, to combat medical conditions such as pulmonary disease and viral pathogens. His work focuses on addressing drug contamination issues to ensure the safety and efficacy of pharmaceutical products.

Framework Evaluation

3 of 3 criteria met
1 Substantial Merit and National Importance Met

The endeavor addresses drug contamination and the development of therapeutics, which is of great importance to the global pharmacy industry and public health.

2 Well-positioned to Advance the Endeavor Met

The petitioner's education, first-authored publications, citation record, and NIH funding demonstrate his ability to advance the field.

3 Waiver of Job Offer and Labor Certification Met

On balance, the petitioner's past record of success and the significance of his contributions to pharmaceutical safety make it beneficial to the U.S. to waive the labor certification.

Why This Petition Was Approved

The petition was approved based on the petitioner's 6 first-authored peer-reviewed journal articles and 80 citations. Evidence included 4 expert recommendation letters, a record of 2 manuscript reviews, and proof of funding from the National Institute of General Medical Sciences (NIGMS) at the NIH.

Evidence

Evidence Types
Peer Reviewed Publications
Citations
Reference Letters Independent
Grants
Original Contributions
Government Alignment

Similar Cases

Chemist

Pharmaceuticals · India

WeGreened EB-2 (NIW) approved
New Jersey 47 days 2025-07-30
The petitioner proposes to apply pharmaceutical science methodologies to streamline drug development and ensure regulatory compliance. Her work focuses on formulation development, analytical validation, and regulatory strategy improvement to reduce the time and cost of bringing drug compounds from the lab to the market.

Scientist

Pharmaceuticals · India

WeGreened EB-2 (NIW) rfe approved
North Carolina 111 days 2025-02-08
The petitioner proposes to improve existing therapies by applying advanced pharmaceutical principles to commercialize biopharmaceuticals and pharmaceuticals. The work focuses on developing innovative drug solubility enhancement methods and non-invasive oral drug delivery systems to treat serious diseases like cancer, AIDS, and kidney failure.

Others

Pharmaceuticals · South Korea

WeGreened EB-2 (NIW) approved
54 days 2025-03-24
The petitioner proposes to continue her research in pharmaceutical science by integrating advanced technologies and computational approaches to develop novel drug candidates. Her work focuses on improving drug delivery systems to create more effective, affordable, and stable medications for chronic diseases including cancer, diabetes, hypertension, and neurodegenerative diseases.

Associate Professor

Pharmaceuticals · Saudi Arabia

WeGreened EB-2 (NIW) approved
505 days 2025-05-16
The petitioner proposes to continue research in pharmaceutics, specifically focusing on drug nano-delivery systems and the development of smart, sustainable alternative drug dosage forms. This work utilizes pharmaceutical technology to improve the deliverability, targetability, efficacy, and safety of drugs. The intended impact is to address critical needs in drug formulation and patient care within the United States.

Frequently Asked Questions

A approved EB-2 NIW (I-140) petition means USCIS determined the petitioner met the eligibility requirements. For appealed cases, "sustained" means the appeal reversed a prior denial. The petitioner can proceed to the next step in the immigration process.

Browse More Cases

Case data sourced from publicly available petition decisions and case studies. Decision date: 2022-03-16.

Browse all cases
View Original

At a Glance

Outcome approved
Processing 97 days
Criteria Met 3 / 3
Evidence Types 6

EB-2 (NIW) Case Data

Scraped Case Data

Total Cases 3,895
Success Rate 54.2%
Sustained 2,112
Dismissed 1,687

Get Case Insights

Compare your profile against thousands of real petition outcomes. Join the waitlist for personalized analysis.

Join Waitlist